Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
1. Australia Diabetes Care Devices Market Outlook to 2018-
Glucose Monitoring and Insulin Delivery
Report Details:
Published:September 2012
No. of Pages: 85
Price: Single User License – US$2500
Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “Australia Diabetes Care Devices Market Outlook to 2018- Glucose
Monitoring and Insulin Delivery” provides key market data on the Australia Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on company financials and pipeline products,
wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Australia Diabetes Care
Devices market.
- Key players covered include F. Hoffmann-La Roche Ltd., Novo Nordisk A/S , Sanofi , Abbott
Laboratories , Eli Lilly and Company , Becton, Dickinson and Company and others.
2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Australia Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/197491-australia-diabetes-care-devices-market-outlook-to-2018-glucose-
monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What is This Report About? 8
3 Diabetes Care Devices In Australia 9
3.1 Diabetes Care Devices, Market Segmentation 9
3.2 Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 10
3.3 Diabetes Care Devices Market, Australia, Revenue Mix ($m), 2011 11
3.4 Diabetes Care Devices Market, Australia, Category Contribution (%), 2011 12
3.5 Diabetes Care Devices, Australia, Company Share (2010-2011) 19
4 Glucose Monitoring In Australia 21
4.1 Glucose Monitoring, Market Segmentation 21
4.2 Glucose Monitoring Market, Australia, Revenue Mix ($m), 2011 22
4.3 Glucose Monitoring Market, Australia, Segment Contribution (%), 2011 23
4.4 Glucose Monitoring Overall Revenue, (2004-2018) 24
4.4.1 Blood Glucose Meters, Revenue (2004-2018) 28
4.5 Glucose Monitoring Overall Volume (2004-2018) 32
4.5.1 Blood Glucose Meters, Volume (2004-2018) 35
4.6 Glucose Monitoring Average Price (2004-2018) 38
4.7 Glucose Monitoring Distribution Share (2010-2011) 39
4.8 Glucose Monitoring, Australia, Company Share (2010-2011) 40
5 Insulin Delivery In Australia 42
5.1 Insulin Delivery, Market Segmentation 42
5.2 Insulin Delivery Market, Australia, Revenue Mix ($m), 2011 43
3. 5.3 Insulin Delivery Market, Australia, Segment Contribution (%), 2011 44
5.4 Insulin Delivery Overall Revenue, (2004-2018) 45
5.4.1 Insulin Pens, Revenue (2004-2018) 49
5.4.2 Insulin Pumps, Revenue (2004-2018) 53
5.5 Insulin Delivery Overall Volume (2004-2018) 55
5.5.1 Insulin Pens, Volume (2004-2018) 59
5.5.2 Insulin Pumps, Volume (2004-2018) 63
5.6 Insulin Delivery Average Price (2004-2018) 65
5.7 Insulin Delivery Distribution Share (2010-2011) 66
5.8 Insulin Delivery, Australia, Company Share (2010-2011) 67
6 Overview of Key Companies in Australia Diabetes Care Devices Market 69
6.1 F. Hoffmann-La Roche Ltd. 69
6.1.1 Company Overview 69
6.1.2 Share in the Australia Diabetes Care Devices Market 69
6.2 Novo Nordisk A/S 70
6.2.1 Company Overview 70
6.2.2 Share in the Australia Diabetes Care Devices Market 70
6.3 Sanofi 71
6.3.1 Company Overview 71
6.3.2 Share in the Australia Diabetes Care Devices Market 71
6.4 Abbott Laboratories 72
6.4.1 Company Overview 72
6.4.2 Share in the Australia Diabetes Care Devices Market 72
6.5 Eli Lilly and Company 73
6.5.1 Company Overview 73
6.5.2 Share in the Australia Diabetes Care Devices Market 73
6.6 Becton, Dickinson and Company 74
6.6.1 Company Overview 74
6.6.2 Share in the Australia Diabetes Care Devices Market 74
6.7 Bayer HealthCare AG 75
6.7.1 Company Overview 75
6.8 Medtronic, Inc. 75
6.8.1 Company Overview 75
6.9 ARKRAY, Inc. 76
6.9.1 Company Overview 76
6.10 Animas Corporation 76
6.10.1 Company Overview 76
6.11 B. Braun Melsungen AG 76
6.11.1 Company Overview 76
7 Diabetes Care Devices Market Pipeline Products 77
8 Appendix 80
8.1 Definitions of Markets Covered in the Report 81
7. Figure 41: Becton, Dickinson and Company, Company Share (%),Australia Diabetes Care Devices
Market, 2011 74
Contact: sales@reportsandreports.com for more information.